ArticleLancet regional health. Americas2022

Cost-effectiveness of stereotactic body radiotherapy versus conventional radiotherapy for the treatment of surgically ineligible stage I non-small cell lung cancer in the Brazilian public health system.

Gustavo Viani Arruda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.